| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | CI-1040 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.005 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.006 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.16 | 0.006 |
| mRNA | BRD-A71883111 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.006 |
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.12 | 0.006 |
| mRNA | AS601245 | GDSC1000 | pan-cancer | AAC | 0.094 | 0.006 |
| mRNA | LY317615 | GDSC1000 | pan-cancer | AAC | 0.09 | 0.007 |
| mRNA | Z-LLNle-CHO | GDSC1000 | pan-cancer | AAC | 0.13 | 0.008 |
| mRNA | BMS-754807 | GDSC1000 | pan-cancer | AAC | 0.088 | 0.008 |